The post Coinbase to Host Monad’s MON Token Sale Ahead of Mainnet Launch appeared on BitcoinEthereumNews.com. Altcoins For years, the promise of open, regulated token sales in the United States has hovered on the horizon but never fully arrived. Key Takeaways Coinbase to host Monad’s first public MON token sale. Sale tests demand for regulated crypto launches. Monad aims to rival Solana with high-speed Layer 1. That changes this month. When the MON token launches on November 17, it will not only introduce the native currency of the Monad blockchain — it will also mark the first public sale hosted through Coinbase’s new global listing platform, a major shift in how early-stage crypto projects reach the public. The sale will last five days and end on November 22, just before Monad’s mainnet goes live. More than a debut, it represents a test of whether the crypto industry can merge transparency, accessibility, and compliance into a single distribution model. A New Model for Token Access Coinbase’s new token-sales hub is its answer to a decade of chaotic coin launches that often excluded U.S. investors or relied on obscure offshore platforms. The exchange has designed a one-stop system that allows vetted projects to sell directly to users in more than 80 countries, including the U.S. Monad will be the first to test this infrastructure. Priced at $0.025 per token, MON will debut with strict participation limits — minimum bids of $100, maximum bids of $100,000, and clear disclosures about allocation and unlock schedules. But the real experiment isn’t in the numbers; it’s in the structure. Unlike the speculative “initial coin offerings” of the 2017 era, Coinbase’s process enforces compliance and transparency, giving the launch a legitimacy many previous projects lacked. Announcing the MON public sale: the first ever token sale on Coinbase The sale starts on November 17th and will be accessible in over 80 countries, including the… The post Coinbase to Host Monad’s MON Token Sale Ahead of Mainnet Launch appeared on BitcoinEthereumNews.com. Altcoins For years, the promise of open, regulated token sales in the United States has hovered on the horizon but never fully arrived. Key Takeaways Coinbase to host Monad’s first public MON token sale. Sale tests demand for regulated crypto launches. Monad aims to rival Solana with high-speed Layer 1. That changes this month. When the MON token launches on November 17, it will not only introduce the native currency of the Monad blockchain — it will also mark the first public sale hosted through Coinbase’s new global listing platform, a major shift in how early-stage crypto projects reach the public. The sale will last five days and end on November 22, just before Monad’s mainnet goes live. More than a debut, it represents a test of whether the crypto industry can merge transparency, accessibility, and compliance into a single distribution model. A New Model for Token Access Coinbase’s new token-sales hub is its answer to a decade of chaotic coin launches that often excluded U.S. investors or relied on obscure offshore platforms. The exchange has designed a one-stop system that allows vetted projects to sell directly to users in more than 80 countries, including the U.S. Monad will be the first to test this infrastructure. Priced at $0.025 per token, MON will debut with strict participation limits — minimum bids of $100, maximum bids of $100,000, and clear disclosures about allocation and unlock schedules. But the real experiment isn’t in the numbers; it’s in the structure. Unlike the speculative “initial coin offerings” of the 2017 era, Coinbase’s process enforces compliance and transparency, giving the launch a legitimacy many previous projects lacked. Announcing the MON public sale: the first ever token sale on Coinbase The sale starts on November 17th and will be accessible in over 80 countries, including the…

Coinbase to Host Monad’s MON Token Sale Ahead of Mainnet Launch

Altcoins

For years, the promise of open, regulated token sales in the United States has hovered on the horizon but never fully arrived.

Key Takeaways
  • Coinbase to host Monad’s first public MON token sale.
  • Sale tests demand for regulated crypto launches.
  • Monad aims to rival Solana with high-speed Layer 1.

That changes this month. When the MON token launches on November 17, it will not only introduce the native currency of the Monad blockchain — it will also mark the first public sale hosted through Coinbase’s new global listing platform, a major shift in how early-stage crypto projects reach the public.

The sale will last five days and end on November 22, just before Monad’s mainnet goes live. More than a debut, it represents a test of whether the crypto industry can merge transparency, accessibility, and compliance into a single distribution model.

A New Model for Token Access

Coinbase’s new token-sales hub is its answer to a decade of chaotic coin launches that often excluded U.S. investors or relied on obscure offshore platforms. The exchange has designed a one-stop system that allows vetted projects to sell directly to users in more than 80 countries, including the U.S.

Monad will be the first to test this infrastructure. Priced at $0.025 per token, MON will debut with strict participation limits — minimum bids of $100, maximum bids of $100,000, and clear disclosures about allocation and unlock schedules.

But the real experiment isn’t in the numbers; it’s in the structure. Unlike the speculative “initial coin offerings” of the 2017 era, Coinbase’s process enforces compliance and transparency, giving the launch a legitimacy many previous projects lacked.

What Monad Is Building

Behind the fanfare is a young blockchain with serious ambition. Founded in 2022, Monad has raised $225 million to develop a high-throughput, Ethereum-compatible Layer 1 network designed to achieve Solana-level performance while maintaining decentralization.

Developers describe Monad as a “parallelized EVM” — a system capable of processing thousands of smart-contract transactions simultaneously, promising faster execution without forcing developers to abandon Ethereum’s programming tools. If it delivers on that goal, Monad could bridge two worlds that have long been rivals.

How the Tokens Are Distributed

According to the Monad Foundation, the project’s tokenomics emphasize long-term stability over short-term speculation. Of the 100 billion MON that will ever exist, only 7.5% — about 7.5 billion tokens — will be sold during the Coinbase event.

Another 3.3% will be distributed via an airdrop for early community members and testnet participants. The remaining 89% of tokens are locked, reserved for future development, the founding team, investors, and a newly formed Category Labs Treasury.

Roughly half of all tokens, about 50.6 billion, will stay inaccessible when the mainnet launches on November 24. These tokens can’t be traded or staked until vesting schedules begin. The Foundation says this deliberate constraint ensures “multi-year alignment” between developers, investors, and the ecosystem’s health.

Why It Matters for Coinbase

For Coinbase, hosting Monad’s sale isn’t just another listing — it’s the start of a new business model. The company recently acquired two crowdfunding platforms, Echo and Sonar, created by trader and commentator Jordan “Cobie” Fish, in a deal valued around $400 million. Those acquisitions paved the way for a token-launch framework built on U.S. regulatory standards.

If MON’s debut succeeds, Coinbase could become the first American exchange to bring the initial token-offering concept back to the mainstream — but with compliance and investor protection at its core.

Analyst Expectations and Market Impact

Market analysts view the MON sale as a barometer of risk appetite among retail investors after a year of tepid participation in new crypto launches. The sale price — $0.025 — values the full supply of MON at around $2.5 billion, but analysts caution that secondary-market pricing will depend heavily on how quickly Monad’s mainnet gains adoption.

Some expect short-term volatility once trading begins, while others see long-term potential if Monad delivers on its performance claims. “If Monad proves its throughput advantage and maintains developer compatibility, it could emerge as one of the top three alternative Layer 1s by transaction capacity,” one fund manager told DeCenter News.

Looking Ahead

With its mainnet set to launch just two days after the public sale ends, Monad’s team faces an intense schedule — and an equally intense spotlight. The MON token offering is more than a fundraising event; it’s a test case for how future networks may raise capital within regulatory boundaries.

Whether it becomes a template for compliant token launches or just another ambitious experiment, the upcoming sale places both Monad and Coinbase at the center of a turning point for the crypto industry — where innovation and regulation may finally learn to coexist.


The information provided in this article is for educational purposes only and does not constitute financial, investment, or trading advice. Coindoo.com does not endorse or recommend any specific investment strategy or cryptocurrency. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.

Author

Alexander Zdravkov is a person who always looks for the logic behind things. He has more than 3 years of experience in the crypto space, where he skillfully identifies new trends in the world of digital currencies. Whether providing in-depth analysis or daily reports on all topics, his deep understanding and enthusiasm for what he does make him a valuable member of the team.

Next article

Source: https://coindoo.com/coinbase-to-host-monads-mon-token-sale-ahead-of-mainnet-launch/

Market Opportunity
TokenFi Logo
TokenFi Price(TOKEN)
$0.003234
$0.003234$0.003234
-0.55%
USD
TokenFi (TOKEN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26